Testimonios de nuestros clientes
Search:
Perform search
Lista de categorías

Doxepin - Sinequan

Nuevo
Búsqueda por letra:ABCDEFGHIJKLMNOPQRSTUVWXYZ
Sinequan
El Sinequan Genérico está dentro de un grupo de medicamentos llamados antidepresivos tricíclicos. Se utiliza para tratar la depresión y la ansiedad.
€0.44
Bookmarks sociales
Choose your language:



Garantíade devolución
Comprasegura

Nuestra página de facturación está certificada por:

Secure shopping certificates

Special Offer!

  • Somaxon and CJ CheilJedang Announce Silenor(R) Collaboration in South Korea - MarketWatch (press release)

    Somaxon and CJ CheilJedang Announce Silenor(R) Collaboration in South KoreaMarketWatch (press release)Silenor is a low-dose (3 mg and 6 mg) oral tablet formulation of doxepin, and is the first and only non-scheduled prescription sleep medication approved to treat insomnia characterized by difficulties with sleep maintenance.

  • Somaxon and CJ CheilJedang Announce Silenor® Collaboration in South Korea - SunHerald.com

    SunHerald.

  • Infinite Itch: Learning to Live With Hives - New York Times (blog)

    New York Times (blog)Infinite Itch: Learning to Live With HivesNew York Times (blog)But doxepin, the drug that finally suppressed the hives, made him so sleepy that he repeatedly dozed off on a desk during six weeks of job training.

  • Infinite itch: Learning to live with hives - Sarasota Herald-Tribune

    Sarasota Herald-TribuneInfinite itch: Learning to live with hivesSarasota Herald-TribuneBut doxepin, the drug that finally suppressed the hives, made him so sleepy that he repeatedly dozed off on a desk during six weeks of job training.

  • Somaxon, CJ CheilJedang sign Silenor commercialization agreement - Pharmaceutical Business Review

    Somaxon, CJ CheilJedang sign Silenor commercialization agreementPharmaceutical Business ReviewSomaxon Pharmaceuticals and CJ CheilJedang have signed a commercialization agreement in South Korea for Silenor (doxepin) to treat insomnia.

    Copyright © www.pastillabarata.com. Todos los derechos reservados.